kullancı1998572619
Silver
- Joined
- May 14, 2025
- Posts
- 739
- Reputation
- 1,449
Öncelikle Şunu Söylemem Lazımki Tüm Dozlar Benim Hangi Compondlara Vücüdümun Nasıl Tepki Verdiğine Göre Yazdım Sizin Belki Aİ + Masteron Yada EQ + Aİ İhtiyacınız Olmaya Bilir Belkide Aİ yada Diğer Anti Östrejen İlaçları Arttırmanız Gerekebilir Bu Yüzden Kendi Vücüdunuzun Nasıl Tepki Verdiğine Bakın ve Kesinlikle Bu İşlere Girmeden
Ayrıca Tüm tablo Normalde PDF Hallinde ve İngilizceydi yazım yanlışları vs olabilir
Ana Compoundlar
Compound | Doz | Sıklık | Süre |
|---|---|---|---|
| Testo E | 500 mg/hafta | Her gün | 1–8 hafta |
| Testo E | 750 mg/hafta | Her gün | 8–20 hafta |
| HGH | 4 IU/gün | Akşam | 1–4 hafta |
| HGH | 6 IU/gün | Akşam | 4–8 hafta |
| HGH | 8 IU/gün | Akşam | 8–16 hafta |
| HGH | 10 IU/gün | Akşam | 16–20 hafta |
| Trenbolon Ace | 30 mg/gün | Her gün | 1–8 hafta |
| Boldenon/EQ | 300 mg/hafta | Haftada 1 kez | 8–20. haftalar |
| Masteron Prop | 300 mg/hafta | Haftada 3 kez | 1–8. haftalar |
Yardımcılar ve Yan Etki Azaltma
Saç Dökülmesi ve Cilt Sağlığı
| Ürün | Doz | Sıklık | Süre |
|---|---|---|---|
| Oral Minoxidil + Accutane | 2.5 mg/gün 10mg/gün | - | - |
| RU58841 | 140ML (1 mL)/gün | - | - |
| Topikal Minoksidil | Günde 1 kez | Sabah & Akşam | - |
| Ketokonazol Şampuan (Nizoral %2) | EOD | - | - |
Östrojen Kontrolü
| Ürün | Doz | Sıklık | Süre |
|---|---|---|---|
| Arimidex | 1 mg | Haftada 3 kez | İhtiyacınız olduğu zamana kadar. |
Karaciğer Desteği
| Ürün | Doz | Sıklık | Süre |
|---|---|---|---|
| İnj Glutatyon | 600 mg | Haftada 3 kez | 1–8 hafta |
| TUDCA | 1 g/gün | 500 mg sabah + 500 mg akşam | 1–20 hafta |
| Glisin | 5 g+/gün | Akşam | - |
| NAC | 1200 mg/gün | 600 mg sabah + 600 mg akşam | - |
| Kolin | 1 g/gün | Sabah | - |
Kalp ve Lipidler
| Ürün | Doz | Sıklık | Süre |
|---|---|---|---|
| Ezetimibe | 10 mg/gün | Sabah veya Akşam | 1–20. haftalar |
| Telmisartan | 40 mg/gün | Sabah | 1–20. haftalar |
| Omega-3 | 3–6 g EPA/DHA | Sabah | - |
| Nebivolol | 5 mg/gün | Akşam | 1–20. haftalar |
| Nattokinase | 2000 FU/gün | Sabah | - |
| Taurin | 3 g/gün | 1.5 g sabah + 1.5 g akşam | - |
| Sarımsak Ekstresi | 600 mg/gün | Sabah | - |
İnsülin Hassasiyeti
| Ürün | Doz | Sıklık | Süre |
|---|---|---|---|
| Berberine | 1 g/gün | Akşam | - |
| Krom | 400 mcg/gün | Öğünlerle birlikte | - |
| Alfa Lipoik Asit (ALA) | 300 mg/gün | En yüksek karbonhidratlı öğünle | - |
Beyin Sağlığı
| Ürün | Doz | Sıklık | Süre |
|---|---|---|---|
| ALCAR (Asetil-L-Karnitin) | 1500 mg/gün | Sabah | - |
| L-Tirozin | 2 g/gün | Sabah | - |
| L-Theanine | 500 mg/gün | Akşam | - |
| Lion's Mane | 3 g/gün | Akşam | - |
| Alpha-GPC | 600 mg/gün | Sabah | - |
| Rhodiola Rosea | 200 mg/gün | Sabah | - |
Uyku ve Antioksidanlar
| Ürün | Doz | Sıklık | Süre |
|---|---|---|---|
| Melatonin | 40 mg/gün | Akşam | - |
| Magnezyum | 2000mg/gün | Akşam | - |
Dozlama:
Testo E – 1–8. haftalar arasında 500 mg ile devam et ardından 8. haftada 750 mga çık Östrojene göre ayarlama yap
E2 yüksek hissediliyorsan EQ veya AI artırılabilir ya da testosteron azalt
E2 düşük hissediliyorsa EQ veya AI azaltılabilir ya da testosteron artır
Her gün enjeksiyon yap
Tren Ace – 8. haftaya kadar günlük 30 mg'da kal Yan etkiler kötüleşirse dozu düşür veya kullanımı komple bırak
Eğer yan etkiler artmadıysa 8. haftadan itibaren ED 60mg 'ya Çıkar
Her gün enjeksiyon yap
Masteron Propionat – 1–8. haftalar arasında haftalık 300 mg. Çok karmaşık değil bu dozu sabit tutabilirsin
Haftada 3 enjeksiyon yap.
Boldenon (EQ) – Kürün 8. haftasında 300 mg ile başla ardından östrojen durumuna göre artır veya azalt.
Haftada 1 kez enjeksiyon yap.
HGH – 1–4. haftalar 4 IU, 4–8 haftalar 6 IU 8–12 haftalar 8 IU, ardından kürün geri kalanında 10 IU cycle sonuna kadar
4 IU'dan 10 IU'ya 20 hafta boyunca kademeli çıkılmasının nedeni HGH kullanımında ortaya çıkan IGF-1 reseptör downregülasyonuna uyum sağlamak
Retatrutide – 1–20. haftalar arasında haftalık 2 mg. Daha fazla iştah baskılanması gerekiyorsa dozu artır
Diğer Herşey Çok Açık ve Anlaşılır Zaten Testo EQ ve Ai Hepsi birbirleriyle Bağlantılı Hepsi Birbirine göre Göre Ayarlanıcak E2 referans içinde tutulucak.
Yan etki düşürmek Ekstra Vücüdu Sağlıklı Tutmak ve Maksimum verimi Almak için Ekstra Yapılıcaklar
bloodpressure takibi
Kan şekeri takibi
Kalp Sağlığı için GÜNLÜK KARDİYO , haftada en az 5 kez 30 dakika. (Eğimli koşu bandı, hız 3, %15 eğim.)
Kan bağışı (hematokrit yüksekse)
Mikroiğneleme (Microneedling) – Haftada 1 kez derma stamp ile
İnsülin Hassasiyeti için
Berberin
Krom (öğünlerle birlikte)
Alfa Lipoik Asit (öğünlerle birlikte)
Günlük Aç Karna Kardiyo
Lean Kalmak %10-15 BF
Birazda Olsa Diyetinize Yeşillik Eklemek
Ekstra Olarak Dümenden Compoundların Mekanizmalarını Yazıyorum
(bu kısım ingilizce olucak gpt anasını sikiyor yazının)
Mechanisms:
Testosterone (and its more potent metabolite dihydrotestosterone, DHT) binds to the androgen receptor inside cells.
This changes gene expression which drives tissue-specific growth and differentiation.
In many tissues, testosterone is converted into DHT via 5α-reductase. DHT is more potent at the androgen receptor, crucial for hair growth, important for body/facial hair and prostate growth during puberty along with many other androgenic aspects.
Its main issue during development is its conversion to estradiol (E2). This causes bone maturation and epiphyseal (growth plate) closure, regulation of height growth timing. Although E2 is critical for brain development (including sexual differentiation and behavior circuits).
HGH is released from the pituitary gland (or injected in your case). It acts primarily on the liver and peripheral tissues. The liver produces IGF-1, which mediates many of HGH’s long-term growth effects.
HGH binds to the growth hormone receptor on target cells. This activates the JAK2–STAT pathway (main signaling cascade). Changes in gene transcription promote growth and metabolic adaptation.
Result: increased protein synthesis signaling and tissue remodeling capacity.
IGF-1 is the primary driver of muscle hypertrophy, bone lengthening (chondrocyte proliferation at growth plates), and tissue repair and regeneration.
At growth plates HGH increases cartilage matrix production indirectly. IGF-1 directly stimulates chondrocyte division and hypertrophy. This leads to longitudinal bone growth (height increase during adolescence, although if you are 18 I'm doubtful your growth plates are still open).
Boldenone diffuses into cells and binds to the androgen receptor. The drug-receptor complex translocates to the nucleus and binds to androgen response elements (AREs) on DNA. This changes the transcription of genes involved in muscle protein synthesis, contractile protein expression (actin, myosin), enzyme regulation, and amino acid utilization.
Net effect: increased muscle protein synthesis and reduced protein breakdown.
Other beneficial effects include:
Resistance training and androgens can increase mechano-growth factor (MGF), a splice variant of IGF-1, and local IGF-1 expression in muscle tissue.
Boldenone contributes via androgen receptor activation, leading to increased transcriptional responsiveness to mechanical loading and enhanced satellite cell activation, which is highly IGF-1 sensitive.
So while it does not directly increase IGF-1, it increases muscle responsiveness to existing IGF-1 signaling.
Boldenone also binds androgen receptors in bone tissue, especially:
Drostanolone diffuses into cells and binds the androgen receptor with high affinity. The drug-receptor complex translocates to the nucleus and binds androgen response elements (AREs) on DNA. This changes transcription of genes involved in muscle protein synthesis, contractile protein expression (actin, myosin), enzyme regulation, and amino acid utilization.
Net effect: increased muscle protein synthesis and reduced protein breakdown (moderate anabolic activity with pronounced androgenic/hardening effects).
Other beneficial effects:
Masteron contributes through potent androgen receptor activation, leading to increased transcriptional responsiveness to mechanical loading and enhanced satellite cell activation, which is highly IGF-1 sensitive.
So while it does not directly increase IGF-1 production, it enhances muscle responsiveness to existing IGF-1 signaling and promotes an anabolic environment.
Trenbolone diffuses into cells and binds the androgen receptor with exceptionally high affinity. This changes transcription of genes involved in muscle protein synthesis, contractile protein expression (actin, myosin), enzyme regulation, and amino acid utilization.
Net effect: dramatically increased muscle protein synthesis and strongly reduced protein breakdown (one of the most potent anabolic effects per milligram).
Other beneficial effects:
Trenbolone contributes through potent androgen receptor activation, leading to increased transcriptional responsiveness to mechanical loading and enhanced satellite cell activation, which is highly IGF-1 sensitive.
So alongside strongly increasing IGF-1 levels and signaling, it dramatically increases muscle responsiveness to existing IGF-1 pathways.
Trenbolone also binds androgen receptors in bone tissue, especially:
Testosterone;
Testosterone is the primary androgen hormone responsible for male sexual differentiation, puberty changes, and many anabolic processes.Testosterone (and its more potent metabolite dihydrotestosterone, DHT) binds to the androgen receptor inside cells.
This changes gene expression which drives tissue-specific growth and differentiation.
In many tissues, testosterone is converted into DHT via 5α-reductase. DHT is more potent at the androgen receptor, crucial for hair growth, important for body/facial hair and prostate growth during puberty along with many other androgenic aspects.
Its main issue during development is its conversion to estradiol (E2). This causes bone maturation and epiphyseal (growth plate) closure, regulation of height growth timing. Although E2 is critical for brain development (including sexual differentiation and behavior circuits).
HGH;
Human Growth Hormone (HGH) and Insulin-like Growth Factor 1 (IGF-1) work together as a linked endocrine axis that drives growth, tissue repair, and metabolic regulation.HGH is released from the pituitary gland (or injected in your case). It acts primarily on the liver and peripheral tissues. The liver produces IGF-1, which mediates many of HGH’s long-term growth effects.
HGH binds to the growth hormone receptor on target cells. This activates the JAK2–STAT pathway (main signaling cascade). Changes in gene transcription promote growth and metabolic adaptation.
Result: increased protein synthesis signaling and tissue remodeling capacity.
IGF-1 is the primary driver of muscle hypertrophy, bone lengthening (chondrocyte proliferation at growth plates), and tissue repair and regeneration.
At growth plates HGH increases cartilage matrix production indirectly. IGF-1 directly stimulates chondrocyte division and hypertrophy. This leads to longitudinal bone growth (height increase during adolescence, although if you are 18 I'm doubtful your growth plates are still open).
Equipoise;
Boldenone undecylenate (Equipoise/EQ) is a synthetic testosterone-derived anabolic androgenic steroid (AAS) with a 1,2-double bond modification, so its effects come primarily through androgen receptor (AR) signaling and downstream changes in gene transcription.Boldenone diffuses into cells and binds to the androgen receptor. The drug-receptor complex translocates to the nucleus and binds to androgen response elements (AREs) on DNA. This changes the transcription of genes involved in muscle protein synthesis, contractile protein expression (actin, myosin), enzyme regulation, and amino acid utilization.
Net effect: increased muscle protein synthesis and reduced protein breakdown.
Other beneficial effects include:
- Anti-catabolic effects (nitrogen retention)
- Improved nutrient partitioning
- Appetite stimulation (leading to higher caloric intake for growth)
- Increased erythropoiesis (red blood cell production via EPO stimulation in the kidneys for better oxygen delivery and endurance)
- Mild aromatization (approximately 50% the rate of testosterone)
- Satellite cell activation
- Metabolic partitioning favoring lean tissue
Resistance training and androgens can increase mechano-growth factor (MGF), a splice variant of IGF-1, and local IGF-1 expression in muscle tissue.
Boldenone contributes via androgen receptor activation, leading to increased transcriptional responsiveness to mechanical loading and enhanced satellite cell activation, which is highly IGF-1 sensitive.
So while it does not directly increase IGF-1, it increases muscle responsiveness to existing IGF-1 signaling.
Boldenone also binds androgen receptors in bone tissue, especially:
- Osteoblasts (bone-forming cells)
- Osteocytes (bone maintenance cells)
- Greater bone formation signaling
- Increased periosteal bone growth (bone thickness, not length)
- Increased mineralization (denser bone matrix)
Masteron
Drostanolone (Masteron, usually as prop ester) is a synthetic DHT-derived anabolic androgenic steroid (AAS) with a 2α-methyl modification, so its effects come primarily through strong androgen receptor (AR) signaling and downstream changes in gene transcription.Drostanolone diffuses into cells and binds the androgen receptor with high affinity. The drug-receptor complex translocates to the nucleus and binds androgen response elements (AREs) on DNA. This changes transcription of genes involved in muscle protein synthesis, contractile protein expression (actin, myosin), enzyme regulation, and amino acid utilization.
Net effect: increased muscle protein synthesis and reduced protein breakdown (moderate anabolic activity with pronounced androgenic/hardening effects).
Other beneficial effects:
- Strong anti-estrogenic activity (competes at estrogen receptors without aromatizing)
- Enhanced muscle hardness and density
- Improved vascularity and definition (especially in low body fat)
- Anti-catabolic effects (nitrogen retention)
- Nutrient partitioning toward lean tissue
- Lowered SHBG (increasing free testosterone)
- No aromatization to estrogen
- Moderate strength gains with minimal water retention
Masteron and IGF-1;
Drostanolone, like other androgens, supports IGF-1 signaling pathways. Resistance training and androgen use can increase Mechano-Growth Factor (MGF) (a splice variant of IGF-1), local IGF-1 expression, and IGF-1 receptor sensitivity in muscle tissue.Masteron contributes through potent androgen receptor activation, leading to increased transcriptional responsiveness to mechanical loading and enhanced satellite cell activation, which is highly IGF-1 sensitive.
So while it does not directly increase IGF-1 production, it enhances muscle responsiveness to existing IGF-1 signaling and promotes an anabolic environment.
Trenbolone
Trenbolone (Tren, usually as acetate(my choice aswell), enanthate, or hexahydrobenzylcarbonate ester) is a synthetic 19-nortestosterone-derived anabolic androgenic steroid (AAS) with multiple modifications (including 19-nor and Δ9,11 structures), so its effects come primarily through extremely potent androgen receptor (AR) signaling and downstream changes in gene transcription.Trenbolone diffuses into cells and binds the androgen receptor with exceptionally high affinity. This changes transcription of genes involved in muscle protein synthesis, contractile protein expression (actin, myosin), enzyme regulation, and amino acid utilization.
Net effect: dramatically increased muscle protein synthesis and strongly reduced protein breakdown (one of the most potent anabolic effects per milligram).
Other beneficial effects:
- Profound anti-catabolic effects (nitrogen retention and cortisol antagonism)
- Exceptional nutrient partitioning (directs calories toward muscle rather than fat)
- Strong lipolytic/fat-burning properties
- Increased red blood cell production and oxygenation
- No aromatization to estrogen
- Massive increases in strength and muscle hardness/density
- Enhanced vascularity
- Elevated feed efficiency (better utilization of food for growth)
Trenbolone and IGF-1;
Trenbolone significantly upregulates IGF-1 production (both systemic and local in muscle tissue). Resistance training and androgens can increase MGF and local IGF-1 expression in muscle tissue.Trenbolone contributes through potent androgen receptor activation, leading to increased transcriptional responsiveness to mechanical loading and enhanced satellite cell activation, which is highly IGF-1 sensitive.
So alongside strongly increasing IGF-1 levels and signaling, it dramatically increases muscle responsiveness to existing IGF-1 pathways.
Trenbolone also binds androgen receptors in bone tissue, especially:
- Osteoblasts (bone-forming cells)
- Osteocytes (bone maintenance cells)
- Increased bone formation signaling
- Increased periosteal bone growth (bone thickness, not length)
- Increased mineralization (denser bone matrix)
Son olarak birkaç tip ve trick
Karın Kaslarınızı Çalışın
Serratuslarınızı İzole Çalışın
Omuzu Kolları (biceps triceps) ve latları Antreman başı çalışın
Last edited:
